##gff-version 3
##sequence-region Q86YL7 1 162
Q86YL7	UniProtKB	Signal peptide	1	22	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17222411;Dbxref=PMID:17222411	
Q86YL7	UniProtKB	Chain	23	162	.	.	.	ID=PRO_0000223875;Note=Podoplanin	
Q86YL7	UniProtKB	Peptide	151	162	.	.	.	ID=PRO_0000442187;Note=29kDa cytosolic podoplanin intracellular domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24275092;Dbxref=PMID:24275092	
Q86YL7	UniProtKB	Topological domain	23	131	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Transmembrane	132	152	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Topological domain	153	162	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Region	133	137	.	.	.	Note=Requires for dimerization and lipid rafts association;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21376833;Dbxref=PMID:21376833	
Q86YL7	UniProtKB	Region	154	155	.	.	.	Note=Requires for interaction with MSN and EZR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17046996;Dbxref=PMID:17046996	
Q86YL7	UniProtKB	Site	150	151	.	.	.	Note=Cleavage%3B by gamma-secretase;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24275092;Dbxref=PMID:24275092	
Q86YL7	UniProtKB	Glycosylation	25	25	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	32	32	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	34	34	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	35	35	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	52	52	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17222411,ECO:0000269|PubMed:25458834;Dbxref=PMID:17222411,PMID:25458834	
Q86YL7	UniProtKB	Glycosylation	55	55	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	65	65	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	66	66	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	76	76	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	85	85	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	86	86	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	88	88	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	89	89	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	96	96	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	98	98	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	100	100	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	102	102	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	106	106	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	107	107	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	109	109	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	110	110	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	117	117	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	119	119	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Glycosylation	120	120	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q86YL7	UniProtKB	Alternative sequence	1	100	.	.	.	ID=VSP_051949;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9651190;Dbxref=PMID:9651190	
Q86YL7	UniProtKB	Alternative sequence	1	42	.	.	.	ID=VSP_046799;Note=In isoform 5 and isoform 6. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86YL7	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_035753;Note=In isoform 3 and isoform 4. M->MLTPLGKFSTAKFAVRLPRVWEARAPSLSGAPAPTPPAPPPSRSSRLGLWPRCFLIFPQLRILLLGPQESNNSTGTM;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:15515019,ECO:0000303|PubMed:16303743,ECO:0000303|Ref.9;Dbxref=PMID:14702039,PMID:15489334,PMID:15515019,PMID:16303743	
Q86YL7	UniProtKB	Alternative sequence	101	123	.	.	.	ID=VSP_051950;Note=In isoform 2. ASNVATSHSTEKVDGDTQTTVEK->MLHILSPMYFFLWGSCFFPLSSS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9651190;Dbxref=PMID:9651190	
Q86YL7	UniProtKB	Alternative sequence	160	162	.	.	.	ID=VSP_035754;Note=In isoform 4. YSP->P;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16303743;Dbxref=PMID:16303743	
Q86YL7	UniProtKB	Alternative sequence	160	161	.	.	.	ID=VSP_046800;Note=In isoform 5. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q86YL7	UniProtKB	Alternative sequence	162	162	.	.	.	ID=VSP_051951;Note=In isoform 2. P->EVNSLHPCDRQMKAIVSRTQIFELIEISDISWVWWLVPVVSAAGQLQTSLGNIVRPCLKKIISGTMVMFQSSLLGPLECSGSHLESQCFERLRRQEVHLCPGI;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9651190;Dbxref=PMID:9651190	
Q86YL7	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_028015;Note=A->G;Dbxref=dbSNP:rs2486188	
Q86YL7	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_028016;Note=A->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10393083,ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:16303743,ECO:0000269|PubMed:9651190,ECO:0000269|Ref.3,ECO:0000269|Ref.9;Dbxref=dbSNP:rs2486188,PMID:10393083,PMID:14702039,PMID:15489334,PMID:16303743,PMID:9651190	
Q86YL7	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Eliminates induction of platelet aggregation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14522983;Dbxref=PMID:14522983	
Q86YL7	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Prevents self-assembly and association to lipid rafts. Reduces the recruitment to invadopodium. Disrupts assembly into adhesion rings. Fails invadopodia-mediated ECM degradation. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21376833,ECO:0000269|PubMed:25486435;Dbxref=PMID:21376833,PMID:25486435	
Q86YL7	UniProtKB	Mutagenesis	154	159	.	.	.	Note=Does not affect localization at cell surface protrusions. Does not induce reorganization of the actin cytoskeleton. Increases cell migration collectively. Does not significant change RHOA activation. No effect on interaction with CD44. Impairs interaction with the EZR and MSN. Impairs epithelial to mesenchymal transition. Does not change localization at invadopodium. Fails to assemble into rings. Fails invadopodia-mediated ECM degradation. RKMSGR->QNMGSN;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17046996,ECO:0000269|PubMed:20962267,ECO:0000269|PubMed:25486435;Dbxref=PMID:17046996,PMID:20962267,PMID:25486435	
Q86YL7	UniProtKB	Mutagenesis	154	155	.	.	.	Note=Impairs interaction with the EZR and MSN. Impairs epithelial to mesenchymal transition. Does not affect localization at cell surface protrusions. Does not induce reorganization of the actin cytoskeleton. Increases cell migration collectively. RK->QN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17046996;Dbxref=PMID:17046996	
Q86YL7	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Highly decreases interaction with the EZR and MSN. Induces an intermediate phenotype between epithelial and mesenchymal. Does not affect localization at cell surface protrusions. Induces reorganization of the actin cytoskeleton oncomitantly with the induced morphological changes. Increases cell migration individually. Increases invasiveness. Enhances RHOA activity. Colocalizes at cell-surface protrusions with RHOA and RAC1. R->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17046996;Dbxref=PMID:17046996	
Q86YL7	UniProtKB	Sequence conflict	57	57	.	.	.	Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
